The Relationship Between Kidney Biomarkers, Inflammation, Severity, and Mortality Due to COVID-19—A Two-Timepoint Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136086 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sara Soares Tozoni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pós-Graduação em Ciências da Saúde, Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba 80215-901, Brazil. Hauptthemen laut MEDLINE: COVID-19, Acute Kidney Injury, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Siemens Healthineers, PUCPR (Pontifícia Universidade Católica do Paraná, Brazil), BRDE (Banco Regional de Desenvolvimento do Extremo Sul).
Abstract (Originalsprache)
About a quarter of COVID-19 patients develop acute kidney injury (AKI), worsening prognosis and increasing mortality. Severe COVID-19 often triggers a hyperactive immune response, influencing disease outcomes. This study examined the correlation between kidney injury biomarkers, inflammatory mediators, and mortality in COVID-19 patients. Blood samples from 390 COVID-19 patients were collected at admission and before the outcome. Serum Cystatin C (CysC), albumin, and plasma NGAL were measured via nephelometry, while inflammatory mediators (IL-4, IL-6, IL-10, IL-15, IFN-γ, TNF-α, and IL-1β) were assessed by ELISA. Most patients were male, with hypertension and diabetes as common comorbidities, and a high ICU admission rate. Lower albumin and elevated CysC and NGAL were linked to mortality. Increased inflammatory mediators correlated with lower albumin and higher CysC and NGAL, reinforcing the connection between systemic inflammation and kidney dysfunction. Elevated cytokines and kidney injury biomarkers, including NGAL, CysC, and low albumin, are strongly associated with higher mortality in COVID-19 patients. These findings highlight the role of inflammation and kidney function markers in identifying high-risk individuals, improving patient management, and mitigating complications. Monitoring these biomarkers remains crucial for managing long-term health impacts and future outbreaks
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pós-Graduação em Ciências da Saúde, Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba 80215-901, Brazil.
ORCID-Profile: Erika Sousa Dias, Julia Bacarin Monte Alegre, Marina de Castro Deus, Thyago Proença de Moraes, Andrea Novais Moreno-Amaral
Förderung
- Siemens Healthineers
- PUCPR (Pontifícia Universidade Católica do Paraná, Brazil)
- BRDE (Banco Regional de Desenvolvimento do Extremo Sul)
- CAPES/CNPq
Zitieren
APA
Tozoni, S. S., Gadotti, A. C., Dias, E. S., Monte Alegre, J. B., Von Spitzenbergen, B. A., Deus, M. C., de Moraes, T. P., & Moreno-Amaral, A. N. (2025). The Relationship Between Kidney Biomarkers, Inflammation, Severity, and Mortality Due to COVID-19—A Two-Timepoint Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136086
Vancouver
Tozoni SS, Gadotti AC, Dias ES, Monte Alegre JB, Von Spitzenbergen BA, Deus MC, et al. The Relationship Between Kidney Biomarkers, Inflammation, Severity, and Mortality Due to COVID-19—A Two-Timepoint Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136086
BibTeX
@article{Tozoni2025,
author = {Tozoni, Sara Soares and Gadotti, Ana Carolina and Dias, Erika Sousa and Monte Alegre, Julia Bacarin and Von Spitzenbergen, Beatriz Akemi and Deus, Marina de Castro and de Moraes, Thyago Proença and Moreno-Amaral, Andrea Novais},
title = {The Relationship Between Kidney Biomarkers, Inflammation, Severity, and Mortality Due to COVID-19—A Two-Timepoint Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136086}
}
EUVIMED